A plethora of SARS-CoV-2 agreements
Vir Biotechnology and Samsung Biologics create large scale manufacturing agreement for SARS-COV-2 antibodies; Vir has also made recent agreements with GlaxoSmithKline plc, Alnylam Pharmaceuticals, Inc., Generation Bio Co. and Biogen Inc.